SLC5A2 and COVID-19: When it comes to COVID-19 hospitalization, SGLT-2 inhibitors were found to be a protective factor against hospitalization (OR 0.555 (95% CI 0.418–0.737)), while sulfonylurea and insulin were found to be risk factors for hospitalization (OR 1.184 (95% CI 1.029–1.362)) and (OR 1.261 (95% CI 1.046–1.520), respectively].